Mendelian randomization applied to pharmaceutical use: the case of metformin and lung cancer

James Yarmolinsky*, Caroline J Bull, Venexia Walker, Aayah G Nounu, George Davey Smith

*Corresponding author for this work

Research output: Contribution to journal › Letter (Academic Journal) › peer-review

5 Citations (Scopus)
102 Downloads (Pure)

Abstract

[No Abstract]
Original languageEnglish
Article numberdyaa059
Number of pages2
JournalInternational Journal of Epidemiology
DOIs
Publication statusPublished - 1 May 2020

Research Groups and Themes

  • ICEP

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-being

Access to Document

  • Full-text PDF (final published version)

    This is the final published version of the article (version of record). It first appeared online via Oxford University Press at https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyaa059/5827679. Please refer to any applicable terms of use of the publisher.

    Final published version, 408 KBLicence: CC BY

Handle.net

    Embargoed Document

  • Full-text PDF (accepted author manuscript)

    Accepted author manuscript, 187 KB

Fingerprint

Dive into the research topics of 'Mendelian randomization applied to pharmaceutical use: the case of metformin and lung cancer'. Together they form a unique fingerprint.
View full fingerprint

Cite this